down arrow

Supriya Lifesci.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
712.60
50.2 (7.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.05 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

699.45740.00

52 Week

330.50841.70
Valuation
Technical
Day's Volume

CASH

4.05 lacs (-27.49%) Volume

Shareholding (Dec 2024)

FII

6.52%

Held by 69 FIIs

DII

4.92%

Held by 4 DIIs

Promoter

68.30%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 16.77%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

With a growth in Net Sales of 11.77%, the company declared Very Positive results in Dec 24

4

Stock is technically in a Mildly Bullish range

5

Majority shareholders : Promoters

 
6

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 5,735 Cr (Mid Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.12%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

19.26%

stock-summary
Price to Book

5.89

Revenue and Profits (1 Year):
Net Sales:
186 Cr
(Quarterly Results - Dec 2024)
Net Profit:
47 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.12%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
25.86%
0%
25.86%
1 Year
87.3%
0.19%
87.49%
2 Years
238.13%
0.63%
238.76%
3 Years
46.87%
0.62%
47.49%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 0.8000000000000002 per share ex-dividend date: Sep-20-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.08%
EBIT Growth (5y)
6.27%
EBIT to Interest (avg)
69.41
Debt to EBITDA (avg)
0.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.70
Tax Ratio
26.55%
Dividend Payout Ratio
5.41%
Pledged Shares
0
Institutional Holding
11.44%
ROCE (avg)
28.88%
ROE (avg)
16.77%
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
33
Price to Book Value
5.88
EV to EBIT
22.79
EV to EBITDA
21.12
EV to Capital Employed
6.35
EV to Sales
7.83
PEG Ratio
0.68
Dividend Yield
0.12%
ROCE (Latest)
25.02%
ROE (Latest)
19.26%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (0.67%)

FIIs

Held by 69 FIIs (6.52%)

Promoter with highest holding

Satish Waman Wagh (67.64%)

Highest Public shareholder

Aditya Birla Sun Life Insurance Company Limited (2.27%)

Individual Investors Holdings

16.28%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 11.77% vs 3.41% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.37% vs 3.38% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "185.65",
          "val2": "166.10",
          "chgp": "11.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "65.95",
          "val2": "64.71",
          "chgp": "1.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.51",
          "val2": "0.43",
          "chgp": "18.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "46.78",
          "val2": "46.15",
          "chgp": "1.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "35.52%",
          "val2": "38.96%",
          "chgp": "-3.44%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 20.07% vs 27.44% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 73.26% vs 24.44% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "326.73",
          "val2": "272.12",
          "chgp": "20.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "127.26",
          "val2": "75.99",
          "chgp": "67.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.76",
          "val2": "1.02",
          "chgp": "-25.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "90.79",
          "val2": "52.40",
          "chgp": "73.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "38.95%",
          "val2": "27.93%",
          "chgp": "11.02%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 24.31% vs 29.35% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 67.38% vs 59.19% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "512.38",
          "val2": "412.19",
          "chgp": "24.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "193.21",
          "val2": "117.47",
          "chgp": "64.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.27",
          "val2": "1.51",
          "chgp": "-15.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "137.57",
          "val2": "82.19",
          "chgp": "67.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "37.71%",
          "val2": "28.50%",
          "chgp": "9.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.74% vs -13.04% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 32.55% vs -40.81% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "570.37",
          "val2": "460.94",
          "chgp": "23.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "172.97",
          "val2": "128.90",
          "chgp": "34.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.11",
          "val2": "3.08",
          "chgp": "-31.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "119.11",
          "val2": "89.86",
          "chgp": "32.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.33%",
          "val2": "27.96%",
          "chgp": "2.37%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
185.65
166.10
11.77%
Operating Profit (PBDIT) excl Other Income
65.95
64.71
1.92%
Interest
0.51
0.43
18.60%
Exceptional Items
0.00
0.00
Standalone Net Profit
46.78
46.15
1.37%
Operating Profit Margin (Excl OI)
35.52%
38.96%
-3.44%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 11.77% vs 3.41% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 1.37% vs 3.38% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
326.73
272.12
20.07%
Operating Profit (PBDIT) excl Other Income
127.26
75.99
67.47%
Interest
0.76
1.02
-25.49%
Exceptional Items
0.00
0.00
Standalone Net Profit
90.79
52.40
73.26%
Operating Profit Margin (Excl OI)
38.95%
27.93%
11.02%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 20.07% vs 27.44% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 73.26% vs 24.44% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
512.38
412.19
24.31%
Operating Profit (PBDIT) excl Other Income
193.21
117.47
64.48%
Interest
1.27
1.51
-15.89%
Exceptional Items
0.00
0.00
Standalone Net Profit
137.57
82.19
67.38%
Operating Profit Margin (Excl OI)
37.71%
28.50%
9.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 24.31% vs 29.35% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 67.38% vs 59.19% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
570.37
460.94
23.74%
Operating Profit (PBDIT) excl Other Income
172.97
128.90
34.19%
Interest
2.11
3.08
-31.49%
Exceptional Items
0.00
0.00
Standalone Net Profit
119.11
89.86
32.55%
Operating Profit Margin (Excl OI)
30.33%
27.96%
2.37%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 23.74% vs -13.04% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 32.55% vs -40.81% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Supriya Lifescience Ltd stock-summary
stock-summary
Supriya Lifescience Ltd
Mid Cap
Pharmaceuticals & Drugs
Supriya Lifescience Limited was initially constituted on October 29, 1985, as a "Partnership Firm under the name `M/s Supriya Chemicals'. The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007. Upon the conversion of `M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as `Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."